Evidence map›Paper›PMID 40140549›Full record

ArticleCommunications biology2025

Multimodal SARS-CoV-2 interactome sketches the virus-host spatial organization.

Guillaume Dugied, Estelle Mn Laurent, Mikaël Attia, Jean-Pascal Gimeno, Kamel Bachiri, Payman Samavarchi-Tehrani, Flora Donati, Yannis Rahou, Sandie Munier, Faustine Amara and 14 more

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Guillaume Dugied *Institut Pasteur, Université Paris Cité, UMR 3569, Centre National de la Recherche Scientifique, Molecular Genetics of RNA Viruses, 28 rue du Docteur Roux, F-75015, Paris, France.
Estelle Mn Laurent *Univ. Lille, Inserm, CHU Lille, U1192 - Protéomique Réponse Inflammatoire Spectrométrie de Masse - PRISM, F-59000, Lille, France.
Mikaël Attia *Institut Pasteur, Université Paris Cité, UMR 3569, Centre National de la Recherche Scientifique, Molecular Genetics of RNA Viruses, 28 rue du Docteur Roux, F-75015, Paris, France.
Jean-Pascal GimenoUniv. Lille, Inserm, CHU Lille, U1192 - Protéomique Réponse Inflammatoire Spectrométrie de Masse - PRISM, F-59000, Lille, France.
Kamel BachiriUniv. Lille, Inserm, CHU Lille, U1192 - Protéomique Réponse Inflammatoire Spectrométrie de Masse - PRISM, F-59000, Lille, France.
Payman Samavarchi-TehraniLunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada.
Flora DonatiInstitut Pasteur, Université Paris Cité, National Reference Center for respiratory viruses, 28 rue du Docteur Roux, F-75015, Paris, France.ORCID http://orcid.org/0000-0003-2862-9751
Yannis RahouInstitut Pasteur, Université Paris Cité, UMR 3569, Centre National de la Recherche Scientifique, Molecular Genetics of RNA Viruses, 28 rue du Docteur Roux, F-75015, Paris, France.
Sandie MunierInstitut Pasteur, Université Paris Cité, UMR 3569, Centre National de la Recherche Scientifique, Molecular Genetics of RNA Viruses, 28 rue du Docteur Roux, F-75015, Paris, France.
Faustine AmaraInstitut Pasteur, Université Paris Cité, UMR 3569, Centre National de la Recherche Scientifique, Molecular Genetics of RNA Viruses, 28 rue du Docteur Roux, F-75015, Paris, France.
Mélanie Dos SantosInstitut Pasteur, Université Paris Cité, UMR 3569, Centre National de la Recherche Scientifique, Molecular Genetics of RNA Viruses, 28 rue du Docteur Roux, F-75015, Paris, France.
Nicolas SolerInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10 -12, 08020, Barcelona, Spain.
Stevenn VolantBioinformatics and Biostatistics Hub, Institut Pasteur, Université Paris Cité, F-75015, Paris, France.
Natalia PietrosemoliBioinformatics and Biostatistics Hub, Institut Pasteur, Université Paris Cité, F-75015, Paris, France.
Anne-Claude GingrasLunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada.ORCID http://orcid.org/0000-0002-6090-4437
Georgios A PavlopoulosInstitute for Fundamental Biomedical Research, BSRC "Alexander Fleming", 34 Fleming Street, 16672, Vari, Greece.ORCID http://orcid.org/0000-0002-4577-8276
Sylvie van der WerfInstitut Pasteur, Université Paris Cité, UMR 3569, Centre National de la Recherche Scientifique, Molecular Genetics of RNA Viruses, 28 rue du Docteur Roux, F-75015, Paris, France.ORCID http://orcid.org/0000-0002-1148-4456
Pascal Falter-BraunInstitute of Network Biology (INET), Molecular Targets and Therapeutics Center (MTTC), Helmholtz Center Munich, German Research Center for Environmental Health, Munich-Neuherberg, Munich, Germany.ORCID http://orcid.org/0000-0003-2012-6746
Patrick AloyInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10 -12, 08020, Barcelona, Spain.
Yves JacobInstitut Pasteur, Université Paris Cité, UMR 3569, Centre National de la Recherche Scientifique, Molecular Genetics of RNA Viruses, 28 rue du Docteur Roux, F-75015, Paris, France.
Anastassia KomarovaInstitut Pasteur, Université Paris Cité, UMR 3569, Centre National de la Recherche Scientifique, Molecular Genetics of RNA Viruses, 28 rue du Docteur Roux, F-75015, Paris, France.
Yorgos SofianatosInstitute for Fundamental Biomedical Research, BSRC "Alexander Fleming", 34 Fleming Street, 16672, Vari, Greece. yorgos@fleming.gr.ORCID http://orcid.org/0009-0001-1109-0211
Etienne CoyaudUniv. Lille, Inserm, CHU Lille, U1192 - Protéomique Réponse Inflammatoire Spectrométrie de Masse - PRISM, F-59000, Lille, France. etienne.coyaud@inserm.fr.ORCID http://orcid.org/0000-0002-5893-4557
Caroline DemeretInstitut Pasteur, Université Paris Cité, UMR 3569, Centre National de la Recherche Scientifique, Molecular Genetics of RNA Viruses, 28 rue du Docteur Roux, F-75015, Paris, France. caroline.demeret@pasteur.fr.ORCID http://orcid.org/0000-0002-1103-6805

Funding

Exploring alternate targets for inhibition of virus infection by PPI disruptionR21AI153738 · NIAID · DANA-FARBER CANCER INST · PI CALDERWOOD, MICHAEL A, DEMERET, CAROLINE · 2021 to 2022
$420k
EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 101003589Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.) R21AI153738NIAID NIH HHS R21 AI153738
6 · The paper itself

Abstract

An accurate spatial representation of protein-protein interaction networks is needed to achieve a realistic and biologically relevant representation of interactomes. Here, we leveraged the spatial information included in Proximity-Dependent Biotin Identification (BioID) interactomes of SARS-CoV-2 proteins to calculate weighted distances and model the organization of the SARS-CoV-2-human interactome in three dimensions (3D) within a cell-like volume. Cell regions with viral occupancy were highlighted, along with the coordination of viral proteins exploiting the cellular machinery. Profiling physical intra-virus and virus-host contacts enabled us to demonstrate both the accuracy and the predictive value of our 3D map for direct interactions, meaning that proteins in closer proximity tend to interact physically. Several functionally important virus-host complexes were detected, and robust structural models were obtained, opening the way to structure-directed drug discovery screens. This PPI discovery pipeline approach brings us closer to a realistic spatial representation of interactomes, which, when applied to viruses or other pathogens, can provide significant information for infection. Thus, it represents a promising tool for coping with emerging infectious diseases.

Indexed as

COVID-19Host-Pathogen InteractionsProtein Interaction MapsSARS-CoV-2Viral ProteinsHumansProtein Interaction MappingViral Proteins

Identifiers

PMID40140549
PMCPMC11947133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.